-
play_arrow
‘Coffee’nomics – Business Behind The Beans Arijit Barman
-
play_arrow
Digital Divide: Who Should Pay for Payments? Anupriya Bahadur
-
play_arrow
The Dolo Debate – Is Pharma Paying for Prescriptions? Kiran Somvanshi
-
play_arrow
Audio Evolution to Podcasting Revolution Anirban Chowdhury
Diabetes Drugs: Bittersweet Truth of Patent Expiries
-
play_arrow
Diabetes Drugs: Bittersweet Truth of Patent Expiries Kiran Somvanshi
With the oral diabetes drugs market at Rs 13,000 crore and growing, a key diabetes medicine Sitagliptin going off patent means a sweet spot for all. How does the billion-dollar pharma industry see an opportunity in a market with the highest number of diabetes patients in the world. Host Kiran Somvanshi chats with Nithya Balasubramanian, Director at AB Bernstein, Sheetal Sapale, Marketing President – AWACS, and Vikas Dandekar, Editor – Pharma at ET Prime.
Credits: CNBC-TV18
Credits : Producers: Vinay Joshi from The Economic Times and Soundarya Jayachandran from Aawaz. Sound editors: Indranil Bhattacharjee from the Economic Times and Swati Joshi from Aawaz Executive Producers : Arijit Barman and Anupria Bahadur from The Economic Times.